These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2845233)

  • 21. IFN-gamma differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity. Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production.
    Leu RW; Leu NR; Shannon BJ; Fast DJ
    J Immunol; 1991 Sep; 147(6):1816-22. PubMed ID: 1909732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of interferon on sensitive and resistant L1210 cell lines.
    Marti J; Vandenbussche P; Silhol M; Milhaud P; Verhaegen M; Content J; Lebleu B
    J Interferon Res; 1981 Feb; 1(2):287-95. PubMed ID: 6180059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of different biological response modifiers on interferon expression in bacterial lipopolysaccharide (LPS)-responsive and LPS-hyporesponsive mouse peritoneal macrophages.
    Di Marzio P; Gessani S; Locardi C; Borghi P; Baglioni C; Belardelli F
    J Gen Virol; 1990 Nov; 71 ( Pt 11)():2585-91. PubMed ID: 1701475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indomethacin and aspirin do not inhibit the antiviral or anti-proliferative actions of interferon.
    Tovey MG; Gresser I; Rochette-Egly C; Begon-Lours-Guymarho J; Bandu MT; Maury C
    J Gen Virol; 1982 Dec; 63(2):505-8. PubMed ID: 6185629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The interaction of interferon-alpha and -gamma: regulation of (2-5)A synthetase activity.
    Fish EN; Hannigan GE; Banerjee K; Williams BR
    Virology; 1988 Jul; 165(1):87-94. PubMed ID: 2455384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PKR is not required for interferon-gamma inhibition of VSV replication in neurons.
    Chesler DA; Muñoz-Jordán JL; Donelan N; García-Sastre A; Reiss CS
    Viral Immunol; 2003; 16(1):87-96. PubMed ID: 12725691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of MuIFN-alpha/beta and MuIFN-gamma-induced antiviral states: differential effects with different challenge viruses and lack of correlation with 2'5' oligoadenylate synthetase levels.
    Ramamurthy V; Fleischmann WR
    J Biol Regul Homeost Agents; 1988; 2(1):7-14. PubMed ID: 2845725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biologic and binding activities of IFN-alpha subtypes in ACHN human renal cell carcinoma cells and Daudi Burkitt's lymphoma cells.
    Yamaoka T; Kojima S; Ichi S; Kashiwazaki Y; Koide T; Sokawa Y
    J Interferon Cytokine Res; 1999 Dec; 19(12):1343-9. PubMed ID: 10638703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of macrophage growth and antiviral activity by interferon-gamma.
    Goldberg M; Belkowski LS; Bloom BR
    J Cell Biol; 1989 Sep; 109(3):1331-40. PubMed ID: 2549078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment of new interferon-gamma-resistant mutant cells with dominant phenotypes.
    Ohta T; Ando O; Kurimoto M
    J Interferon Cytokine Res; 1995 Feb; 15(2):153-60. PubMed ID: 8590319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor necrosis factor up-regulates gamma-interferon binding in a human carcinoma cell line.
    Raitano AB; Korc M
    J Biol Chem; 1990 Jun; 265(18):10466-72. PubMed ID: 2141333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of gene expression by intracellular interferon-gamma: abrogation of the species specificity barrier.
    Lewis JA; Huq A; Liu W; Jacob A
    Virology; 1995 Oct; 212(2):438-50. PubMed ID: 7571413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antisense manganese superoxide dismutase mRNA inhibits the antiviral action of interferon-gamma and interferon-alpha.
    Raineri I; Huang TT; Epstein CJ; Epstein LB
    J Interferon Cytokine Res; 1996 Jan; 16(1):61-8. PubMed ID: 8640453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of interferon receptor expression during combination beta ser-interferon and gamma-interferon treatment of human colon carcinoma cells.
    Schiller JH; Bushmeyer SM; Ruzicka FJ; Princler GL; Faltynek CR; Borden EC
    Cancer Res; 1990 Jan; 50(1):26-31. PubMed ID: 2136700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction by vasoactive intestinal peptide of interferon alpha/beta synthesis in glial cells but not in neurons.
    Chelbi-Alix MK; Brouard A; Boissard C; Pelaprat D; Rostene W; Thang MN
    J Cell Physiol; 1994 Jan; 158(1):47-54. PubMed ID: 7505279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preferential effect of gamma interferon on the synthesis of HLA antigens and their mRNAs in human cells.
    Wallach D; Fellous M; Revel M
    Nature; 1982 Oct; 299(5886):833-6. PubMed ID: 6290893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiviral activity of tumour necrosis factor. Synergism with interferons and induction of oligo-2',5'-adenylate synthetase.
    Mestan J; Brockhaus M; Kirchner H; Jacobsen H
    J Gen Virol; 1988 Dec; 69 ( Pt 12)():3113-20. PubMed ID: 2462015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure/function studies on recombinant human gamma interferon.
    Fish EN; Banerjee K; Arakawa T; Stebbing N
    Drug Des Deliv; 1988 Feb; 2(3):191-206. PubMed ID: 2855574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of murine and human interferon-gamma receptor expression by their ligands or phorbol ester.
    Bader T; Wietzerbin J
    Cytokine; 1994 Jan; 6(1):70-8. PubMed ID: 8003636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of human gamma interferon on cell growth, replication of virus and induction of 2'-5'oligoadenylate synthetase in three human lymphoblastoid cell lines and K562 cells.
    Tomita Y; Cantell K; Kuwata T
    Int J Cancer; 1982 Aug; 30(2):161-5. PubMed ID: 6182110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.